Maria Cassano had a dissociative disorder for 20 years, and had no idea because she thought she was just stressed out.
By reducing dissociation and sedation risk, ALA-3000 may eliminate the ≥2-hour post-dose monitoring requirement, reducing clinic operating costs, ...
A type of mental health condition consists of memory micro-dissociations. I explain what this is. AI can help people in mild instances. An AI Insider scoop.
An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression ...
Vietnam Investment Review on MSN
Alar reports positive Phase 1 results for long-acting ketamine therapy
TAICHUNG, April 6, 2026 /PRNewswire/ -- Alar Pharmaceuticals Inc. (Alar, TPEx:6785), a clinical-stage biopharmaceutical company focused on developing long-acting injectables (LAIs), today announced ...
Alar’s ketamine-based drug mitigates certain adverse events, which could eliminate the need for post-dose monitoring.
EBGLYSS (lebrikizumab-lbkz) delivered durable skin clearance and relief from persistent itch for up to four years for ...
Lilly's Ebglyss delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis: Indianapolis Monday, March 30, 2026, 12:00 Hrs [IST] ...
Patients with treatment-resistant depression who engaged in a single day of treatment with inhaled mebufotenin reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results